Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Tournigand

Showing results (21-30 of 47) with videos related to

Pageof 5
Sort By:
Circulation|December 4, 2002
Influence of tamoxifen on carotid intima-media thickness in postmenopausal womenT Simon, P Boutouyrie, J M Simon, et al.
Journal De Gynecologie, Obstetrique Et Biologie De La Reproduction|February 2, 2010
[Lobular intra-epithelial neoplasia: atypical lobular hyperplasia and lobular carcinoma in situ]Y Ansquer, P Santulli, C Colas, et al.
Cancer Medicine|December 3, 2024
"The Truth Is, We Must Miss Some": A Qualitative Study of the Patient Eligibility Screening Process, and Automation Perspectives, for Cancer Clinical TrialsA La Rosa, M Vaterkowski, M Cuggia, et al.
European Journal of Cancer (Oxford, England : 1990)|March 28, 2002
Optimisation of 5-fluorouracil (5-FU)/cisplatin combination chemotherapy with a new schedule of hydroxyurea, leucovorin, 5-FU and cisplatin (HLFP regimen) for metastatic oesophageal cancerJ Taïeb, P Artru, B Baujat, et al.
Cancer|March 15, 1997
Bimonthly high dose leucovorin and 5-fluorouracil 48-hour continuous infusion in patients with advanced colorectal carcinoma. Groupe d'Etude et de Recherche sur les Cancers de l'Ovaire et Digestifs (GERCOD)K Beerblock, Y Rinaldi, T André, et al.
Cancer|March 15, 1997
Bimonthly high dose leucovorin and 5-fluorouracil 48-hour infusion with interferon-alpha-2a in patients with advanced colorectal carcinoma. Groupe d'Etude et de Recherche sur les Cancers de l'Ovaire et Digestifs (GERCOD)C Tournigand, C Louvet, A de Gramont, et al.
European Journal of Cancer (Oxford, England : 1990)|February 1, 1997
Oxaliplatin with high-dose leucovorin and 5-fluorouracil 48-hour continuous infusion in pretreated metastatic colorectal cancerA de Gramont, J Vignoud, C Tournigand, et al.
La Revue De Medecine Interne|January 28, 2004
[Long term survival in metastatic colorectal cancer treated with leucovorin and 5-fluoro-uracil chemotherapy]N Perez, C Tournigand, M Mabro, et al.
Gynecologic Oncology|October 19, 2001
Intravenous chemotherapy, early debulking surgery, and consolidation intraperitoneal chemotherapy in advanced ovarian carcinomaC Tournigand, C Louvet, J L Molitor, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 18, 2011
Immunogenicity and safety of the influenza A H1N1v 2009 vaccine in cancer patients treated with cytotoxic chemotherapy and/or targeted therapy: the VACANCE studyB Rousseau, P Loulergue, O Mir, et al.
Pageof 5

Showing results (21-30 of 47) with videos related to

Sort By:
Pageof 5
Circulation|December 4, 2002
Influence of tamoxifen on carotid intima-media thickness in postmenopausal womenT Simon, P Boutouyrie, J M Simon, et al.
Journal De Gynecologie, Obstetrique Et Biologie De La Reproduction|February 2, 2010
[Lobular intra-epithelial neoplasia: atypical lobular hyperplasia and lobular carcinoma in situ]Y Ansquer, P Santulli, C Colas, et al.
Cancer Medicine|December 3, 2024
"The Truth Is, We Must Miss Some": A Qualitative Study of the Patient Eligibility Screening Process, and Automation Perspectives, for Cancer Clinical TrialsA La Rosa, M Vaterkowski, M Cuggia, et al.
European Journal of Cancer (Oxford, England : 1990)|March 28, 2002
Optimisation of 5-fluorouracil (5-FU)/cisplatin combination chemotherapy with a new schedule of hydroxyurea, leucovorin, 5-FU and cisplatin (HLFP regimen) for metastatic oesophageal cancerJ Taïeb, P Artru, B Baujat, et al.
Cancer|March 15, 1997
Bimonthly high dose leucovorin and 5-fluorouracil 48-hour continuous infusion in patients with advanced colorectal carcinoma. Groupe d'Etude et de Recherche sur les Cancers de l'Ovaire et Digestifs (GERCOD)K Beerblock, Y Rinaldi, T André, et al.
Cancer|March 15, 1997
Bimonthly high dose leucovorin and 5-fluorouracil 48-hour infusion with interferon-alpha-2a in patients with advanced colorectal carcinoma. Groupe d'Etude et de Recherche sur les Cancers de l'Ovaire et Digestifs (GERCOD)C Tournigand, C Louvet, A de Gramont, et al.
European Journal of Cancer (Oxford, England : 1990)|February 1, 1997
Oxaliplatin with high-dose leucovorin and 5-fluorouracil 48-hour continuous infusion in pretreated metastatic colorectal cancerA de Gramont, J Vignoud, C Tournigand, et al.
La Revue De Medecine Interne|January 28, 2004
[Long term survival in metastatic colorectal cancer treated with leucovorin and 5-fluoro-uracil chemotherapy]N Perez, C Tournigand, M Mabro, et al.
Gynecologic Oncology|October 19, 2001
Intravenous chemotherapy, early debulking surgery, and consolidation intraperitoneal chemotherapy in advanced ovarian carcinomaC Tournigand, C Louvet, J L Molitor, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 18, 2011
Immunogenicity and safety of the influenza A H1N1v 2009 vaccine in cancer patients treated with cytotoxic chemotherapy and/or targeted therapy: the VACANCE studyB Rousseau, P Loulergue, O Mir, et al.
Pageof 5